28.11.2012 Views

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

REFERENCES<br />

Davies K. J. (2001) Degradation <strong>of</strong> oxidized prote<strong>in</strong>s by the 20S proteasome. Biochimie 83, 301–<br />

190<br />

310.<br />

Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Ca<strong>in</strong>e E. D., Reichert C. M. and Kop<strong>in</strong> I. J.<br />

(1979) Chronic Park<strong>in</strong>sonism secondary to <strong>in</strong>travenous <strong>in</strong>jection <strong>of</strong> meperid<strong>in</strong>e analogues.<br />

Psychiatry Res. 1, 249-254.<br />

Dawson T. M. and Dawson V. L. (2003) Rare genetic mutations shed light on the pathogenesis<br />

<strong>of</strong> Park<strong>in</strong>son disease. J. Cl<strong>in</strong>. Invest. 111, 145–151.<br />

de Lau L. M. and Breteler M. M. (2006) Epidemiology <strong>of</strong> Park<strong>in</strong>son’s disease. Lancet Neurol. 5,<br />

525–535.<br />

de Lau L. M., Giesbergen P. C., de Rijk M. C., H<strong>of</strong>man A., Koudstaal P. J. and Breteler M. M.<br />

(2004) Incidence <strong>of</strong> park<strong>in</strong>sonism and Park<strong>in</strong>son disease <strong>in</strong> a general population: the<br />

Rotterdam Study. Neurology 63, 1240–1244.<br />

de Rijk M. C., Breteler M. M., Graveland G. A., Ott A., Grobee D. E., van der Meché F. G. and<br />

H<strong>of</strong>man A. (1995) Prevalence <strong>of</strong> Park<strong>in</strong>son’s disease <strong>in</strong> the elderly: the Rotterdam Study.<br />

Neurology 45, 2143–2146.<br />

de Rijk M. C., Rocca W. A., Anderson D. W., Melcon M. O., Breteler M. M. and Maraganore D.<br />

M. (1997a) A population perspective on diagnostic criteria for Park<strong>in</strong>son’s disease.<br />

Neurology 48, 1277–1281.<br />

de Rijk M. C., Tzourio C., Breteler M. M., Dartigues J. F., Amaducci L., Lopez-Pousa S.,<br />

Manubens-Bertran J. M., Alpérovitch A. and Rocca W. A. (1997b) Prevalence <strong>of</strong><br />

park<strong>in</strong>sonism and Park<strong>in</strong>son's disease <strong>in</strong> Europe: the EUROPARKINSON Collaborative Study.<br />

European Community Concerted Action on the Epidemiology <strong>of</strong> Park<strong>in</strong>son's disease, J.<br />

Neurol. Neurosurg. Psychiatry 62, 10–15.<br />

Deloncle R., Huguet F., Bab<strong>in</strong> P., Fernández B., Quellard N. and Guillard O. (1999) Chronic<br />

adm<strong>in</strong>istration <strong>of</strong> <strong>alum<strong>in</strong>ium</strong> L-glutamate <strong>in</strong> young mature rats: effects on iron levels and<br />

lipid peroxidation <strong>in</strong> selected bra<strong>in</strong> areas. Toxicol. Lett. 104, 65–73.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!